Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for HIV-associated neuropathic pain
NCT00232141Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in neuropathic pain comparing Pregabalin with Placebo (2 arms). Primary endpoint: Numerical Rating Scale Pain Score at 14 weeks. Started Oct 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00232141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232141.